These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 30522198)

  • 1. [Research progress of biomarkers in early stage lung cancer].
    Ouyang Yuqing YQ; Ni Lianfang LF; Liu Xinmin XM
    Zhonghua Jie He He Hu Xi Za Zhi; 2018 Dec; 41(12):979-981. PubMed ID: 30522198
    [No Abstract]   [Full Text] [Related]  

  • 2. EUS-FNA and biomarkers for the staging of non-small cell lung cancer.
    Al-Haddad M; Wallace MB
    Endoscopy; 2006 Jun; 38 Suppl 1():S114-7. PubMed ID: 16802242
    [No Abstract]   [Full Text] [Related]  

  • 3. Glycine decarboxylase and HIF-1α expression are negative prognostic factors in primary resected early-stage non-small cell lung cancer.
    Berezowska S; Galván JA; Langer R; Bubendorf L; Savic S; Gugger M; Schmid RA; Marti TM
    Virchows Arch; 2017 Mar; 470(3):323-330. PubMed ID: 28062918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of circulating c-met messenger RNA is significantly correlated with nodal stage and early recurrence in non-small cell lung cancer.
    Cheng TL; Chang MY; Huang SY; Sheu CC; Kao EL; Cheng YJ; Chong IW
    Chest; 2005 Sep; 128(3):1453-60. PubMed ID: 16162743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond TNM: Searching for New Patient-Centric Prognostic Indicators in NSCLC.
    Saffarzadeh AG; Blasberg JD
    Ann Surg Oncol; 2018 Nov; 25(12):3425-3426. PubMed ID: 30155757
    [No Abstract]   [Full Text] [Related]  

  • 6. [IHC, FISH, CISH, NGS in non-small cell lung cancer: What changes in the biomarker era?].
    Hamard C; Mignard X; Pecuchet N; Mathiot N; Blons H; Laurent-Puig P; Leroy K; Lupo A; Chapron J; Giraud F; Arrondeau J; Goldwasser F; Alifano M; Damotte D; Wislez M
    Rev Pneumol Clin; 2018 Oct; 74(5):327-338. PubMed ID: 30343945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of 18F-FDG uptake in non-small cell lung cancer: a feasible prognostic marker?
    Buck AK; Glatting G; Reske SN
    J Nucl Med; 2004 Aug; 45(8):1274-6. PubMed ID: 15299047
    [No Abstract]   [Full Text] [Related]  

  • 8. A typical presentation of primary pulmonary epithelioid sarcoma misdiagnosed as non-small cell lung cancer.
    Emori M; Tamakawa M; Kaya M; Takada K; Murase K; Fujita C; Sato S; Takahashi R; Hatanaka KC; Sugita S; Hirano H; Yamashita T; Hasegawa T
    Pathol Int; 2017 Apr; 67(4):222-224. PubMed ID: 28078765
    [No Abstract]   [Full Text] [Related]  

  • 9. Expression of flotillin-2 in human non-small cell lung cancer and its correlation with tumor progression and patient survival.
    Wang YL; Yao WJ; Guo L; Xi HF; Li SY; Wang ZM
    Int J Clin Exp Pathol; 2015; 8(1):601-7. PubMed ID: 25755751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic-Based Approaches for the Study of Cytokines in Lung Cancer.
    Marrugal Á; Ojeda L; Paz-Ares L; Molina-Pinelo S; Ferrer I
    Dis Markers; 2016; 2016():2138627. PubMed ID: 27445423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers in the accurate subclassification of non-small-cell lung carcinoma for targeted therapy: issues and prospects.
    Osmani L; Li QK
    Biomark Med; 2017 May; 11(5):405-407. PubMed ID: 28621614
    [No Abstract]   [Full Text] [Related]  

  • 12. Overexpression of γ-tubulin in non-small cell lung cancer.
    Maounis NF; Dráberová E; Mahera E; Chorti M; Caracciolo V; Sulimenko T; Riga D; Trakas N; Emmanouilidou A; Giordano A; Dráber P; Katsetos CD
    Histol Histopathol; 2012 Sep; 27(9):1183-94. PubMed ID: 22806905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NOB1 expression predicts early response to cisplatin-based chemotherapy in patients with advanced non-small cell lung cancer.
    Liu K; Chen HL; Gu MM; You QS
    J Chemother; 2016 Jun; 28(3):225-9. PubMed ID: 25971309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of EML4-ALK fusion gene as a biomarker in non-small cell lung cancer].
    Wang L; Wang YH; Liu CY; Han M; Zhang SP; Lai RS
    Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):788-90. PubMed ID: 22336170
    [No Abstract]   [Full Text] [Related]  

  • 15. Exhaled Breath Analysis for Monitoring Response to Treatment in Advanced Lung Cancer.
    Nardi-Agmon I; Abud-Hawa M; Liran O; Gai-Mor N; Ilouze M; Onn A; Bar J; Shlomi D; Haick H; Peled N
    J Thorac Oncol; 2016 Jun; 11(6):827-37. PubMed ID: 26968885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated expression of FABP3 and FABP4 cooperatively correlates with poor prognosis in non-small cell lung cancer (NSCLC).
    Tang Z; Shen Q; Xie H; Zhou X; Li J; Feng J; Liu H; Wang W; Zhang S; Ni S
    Oncotarget; 2016 Jul; 7(29):46253-46262. PubMed ID: 27323829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and prognostic significance of OPN and VEGF expression in patients with non-small-cell lung cancer.
    Lin Q; Guo L; Lin G; Chen Z; Chen T; Lin J; Zhang B; Gu X
    Cancer Epidemiol; 2015 Aug; 39(4):539-44. PubMed ID: 26123318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 16th World Conference on Lung Cancer.
    Landman A
    Lancet Oncol; 2015 Oct; 16(13):1290. PubMed ID: 26387750
    [No Abstract]   [Full Text] [Related]  

  • 19. A peptide selected by biopanning identifies the integrin alphavbeta6 as a prognostic biomarker for nonsmall cell lung cancer.
    Elayadi AN; Samli KN; Prudkin L; Liu YH; Bian A; Xie XJ; Wistuba II; Roth JA; McGuire MJ; Brown KC
    Cancer Res; 2007 Jun; 67(12):5889-95. PubMed ID: 17575158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic correlation of programmed death ligand-1 expression in non-small cell lung carcinomas: A report from India.
    Vallonthaiel AG; Malik PS; Singh V; Kumar V; Kumar S; Sharma MC; Mathur S; Arava S; Guleria R; Jain D
    Ann Diagn Pathol; 2017 Dec; 31():56-61. PubMed ID: 29146060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.